High levels of CXCR4 have been shown to indicate particularly aggressive disease, metastasis, or poor prognosis in solid cancers (Teicher & Fricker, 2010; Weilbaecher et al, 2011) and AML (Spoo et al, 2007). Here, CXCR4 is linked to acute myeloid leukemia.